Siemens Healthineers Expands ‘Make in India’ with Local Production of Artis One Edition X

Table of Contents

On Tuesday, April 7, 2026, Siemens Healthineers officially announced the expansion of its “Make in India” operations with the local production of the Artis One Edition X angiography system at its Bengaluru facility.

This move marks a significant milestone in India’s medical technology landscape, as the Bengaluru plant becomes a global hub for manufacturing high-end interventional imaging systems, alongside its existing production of MRI, CT, and Digital X-ray units.


The Artis One Edition X: A Universal Workhorse

The Artis One Edition X is designed as a “truly universal” system, meaning it is engineered to handle a broad mix of procedures—from routine cardiology to complex peripheral vascular interventions—in a compact footprint.

  • Imaging Excellence: Features the Megalix Cat Plus X-ray tube with flat emitter technology, allowing for high-detailed visibility of fine vessels and stents.
  • Workflow Efficiency: Equipped with StraightView technology, ensuring images always remain upright on the display regardless of the C-arm’s rotation.
  • Space-Saving Design: The system requires only 25 square meters of floor space, compared to the 45 square meters typically needed for ceiling-mounted systems, making it ideal for tier-2 and tier-3 hospitals with limited infrastructure.
  • Automation: Incorporates HeartSweep, allowing for a single-button sweep to acquire all necessary angulations for coronary diagnostics.

Strategic Rationale: Addressing the “Cath Lab Gap”

India’s cardiovascular disease (CVD) burden is rising, yet the infrastructure to treat it remains severely undersupplied.

  1. Low Density: Current data suggests India has only 1.5 to 1.75 cath labs per million people, compared to 12–15 per million in developed markets.
  2. Tier 2/3 Expansion: By manufacturing the Artis One locally, Siemens Healthineers is lowering the cost of entry for smaller hospitals, facilitating the spread of cardiac care beyond metropolitan hubs.
  3. Broad Clinical Utility: The system’s ability to treat heart disease, kidney failure (dialysis shunt revisions), and irregular rhythms makes it a high-ROI asset for multi-specialty hospitals.

Siemens Healthineers in India (2026)

The Bengaluru factory is part of a larger, integrated ecosystem that has seen over ₹1,300 crore in cumulative investment over the past five years.

AspectDetails
WorkforceOver 7,000 employees across India, including a massive R&D and software center.
PortfolioLocally manufactures MAGNETOM Free.Star (Helium-free MRI), CT scanners, and now Advanced Therapy systems.
Policy SupportThe expansion is heavily supported by the Government of India’s Production Linked Incentive (PLI) scheme for medical devices.